Familial dementia caused by polymerization of mutant neuroserpin

Nature

Volumn 401, Issue 6751, 1999, Pages 376-379

  Davis, Richard L ^a   Shrimpton, Antony E ^a   Holohan, Peter D ^a   Bradshaw, Charles ^a   Feiglin, David ^a   Collins, George H ^a   Sonderegger, Peter ^b   Kinter, Jochen ^e   Becker, Lyn Marie ^a   Lacbawan, Felicitas ^c   Krasnewich, Donna ^c   Muenke, Maximillan ^c   Lawrence, Daniel A ^d   Yerby, Mark S ^e   Shaw, Cheng Mel ^f   Gooptu, Bibek ^g   Elliott, Peter R ^g   Finch, John T ^h   Carrell, Robin W ^g   Lomas, David A ^g  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d HOLLAND LABORATORY   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEMENTIA; FAMILIAL DISEASE; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; MOLECULAR BIOLOGY; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN POLYMERIZATION;

BIOPOLYMERS; CEREBRAL CORTEX; DEMENTIA; FEMALE; HUMANS; INCLUSION BODIES; MALE; NEUROPEPTIDES; POINT MUTATION; PROLINE; SERINE; SERPINS;

EID: 0033598346     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/43897     Document Type: Article

References (26)

1. Lansbury, P. T. Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19, 1151-1154 (1997).
2. Kakizuka, A. Protein precipitation: A common etiology in neurodegenerative disorders? Trends Genet. 14, 396-402 (1998).
3. Tran, P. B. & Miller, R. J. Aggregates in neurodegenerative disease: Crowds and power? Trends Neurosci. 22, 194-197 (1999).
4. Carrell, R. W. & Lomas, D. A. Conformational disease. Lancet 350, 134-138 (1997).
5. Carrell, R. W. & Gooptu, B. Conformational changes and disease-serpins, prions and Alzheimer's. Curr. Opin. Struct. Biol. 8, 799-809 (1998).
6. Osterwalder, T., Contartese, J., Stoeckli, E. T., Kuhn, T. B. & Sonderegger, P. Neuroserpin, an axonally secreted serine protease inhibitor. EMBO J. 15, 2944-2953 (1996).
7. Hastings, C. A. et al. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. J. Biol. Chem. 272, 33062-33067 (1997).
8. 1-antitrypsin-deficient variant with a mutation on a predicted conserved residue of the serpin backbone. J. Biol. Chem. 266, 12627-12631 (1991).
9. Yerby, M.S., Shaw, C.-M. & Watson, J. M. D. Progressive dementia and epilepsy in a young adult: Unusual intraneuronal inclusions. Neurology 36, 68-71 (1986).
10. Cervos-Navarro, & Urich, H. Metabolic and Degenerative Diseases of the Central Nervous System. Pathology, Biochemistry, and Genetics (Academic Press, San Diego, 1995).
11. Schrimpf, S. P. et al. Human neuroserpin (PI12): cDNA cloning and chromosomal localization to 3q26. Genomics 40, 55-62 (1997).
12. 1-antitrypsin for structure and function of serpins. Biochemistry 28, 8951-8966 (1989).
13. Lomas, D. A., Evans, D. L., Finch, J. T. & Carrell, R. W. The mechanism of Z α 1-antitrypsin accumulation in the liver. Nature 357, 605-607 (1992).
14. Eriksson, S., Carolson, I. & Velez, R. Risk of cirrhosis and primary liver cancer in α-antitrypsin deficiency. N. Engl. J. Med. 314, 736-739 (1986).
15. Stein, P. E. & Carrell, R. W. What do dysfunctional serpins tell us about molecular mobility and disease? Nature Struct. Biol. 2, 96-113 (1995).
16. 53 → Phe); further evidence for intracellular loop-sheet polymerization. J. Biol. Chem. 268, 15333-15335 (1993).
17. Beauchamp, N. J. et al. Antithrombins wibble and wobble (T85M/K): Archetypal conformational disease with in vivo latent-transition, thrombosis and heparin activation. Blood 92, 2696-2706 (1998).
18. Aulak, K. S. et al. A hinge region mutation in C1-inhibitor (Ala 436 → Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J. Biol. Chem. 268, 18088-18094 (1993).
19. Eldering, E., Verpy, E., Roern, D., Meo, T. & Tosi, M. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J. Biol. Chem. 270, 2579-2587 (1995).
20. Prusiner, S. B. Prion diseases of humans and animals. J. R. Coll. Phys. 28, 1-30 (1994).
21. Yankner, B. A. New clues to Alzheimer's disease: unravelling the roles of amyloid and tau. Nature Med. 2, 850-851 (1996).
22. Mahadeva, R. & Lomas, D. A. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 53, 1022-1024 (1998).
23. Shrimpton, A. E., Browitz, D. & Swender, P. CF mutation analysis in upstate New York. Hum. Mutat. 10, 436-442 (1997).
24. Wallace, A. J., Williamson, P., Mountford, R. C. & Ramsden, S. C. Non-isotopic detection of microsatellite repeats using silver staining. J. Med. Genet. 30, 346-347 (1993).
25. Kraulis, P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
26. 1-antitrypsin. Nature Struct. Biol. 3, 676-681 (1996).